Literature DB >> 23205138

GRP78 and GAL3, differentially regulated by lymph node homogenates, as potential biomarkers for lymph node metastasis in mouse hepatocellular carcinoma cells.

Wenjun Zhu1, Lawrence Owusu, Shizhu Zang, Yunjuan Zhang, Yi Xin, Chao Yan.   

Abstract

In order to systematically evaluate the influence of lymph nodes (LNs) in lymph node metastases (LNM) of hepatocellular carcinoma (HCC), we set up a new in vitro model in which Hca-F and Hca-P cells were cultured in medium containing lymph node homogenates (LNHs). Differential protein expression was measured by two-dimensional gel electrophoresis (2-DE) combined with matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry (MALDI TOF/TOF MS). Results from protein identification revealed two metastatic correlative proteins, 78-kDa glucose-regulated protein (GRP78) and galectin-3 (GAL3). Western blotting confirmed that GRP78, a protein positively correlated with metastasis, increased 2.4-fold in Hca-F cells but decreased to almost a half in Hca-P cells (P<0.05). However, GAL3, a protein negatively correlated with metastasis, was decreased by a half in Hca-F cells but slightly increased non-significantly in Hca-P cells. Thus, our results reveal that some components of LNHs may facilitate a permissive environment for cancer cells with high metastasis potential to eventually metastasize. GRP78 and GAL3 may serve as potential biomarkers for the diagnosis of LNM in HCC.

Entities:  

Year:  2012        PMID: 23205138      PMCID: PMC3506725          DOI: 10.3892/ol.2012.915

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

Review 1.  Role of the heat shock response and molecular chaperones in oncogenesis and cell death.

Authors:  C Jolly; R I Morimoto
Journal:  J Natl Cancer Inst       Date:  2000-10-04       Impact factor: 13.506

2.  Identify lymphatic metastasis-associated genes in mouse hepatocarcinoma cell lines using gene chip.

Authors:  Bo Song; Jian-Wu Tang; Bo Wang; Xiao-Nan Cui; Li Hou; Lu Sun; Li-Min Mao; Chun-Hui Zhou; Yue Du; Li-Hui Wang; Hua-Xin Wang; Ren-Shu Zheng; Lei Sun
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

Review 3.  The role of the organ microenvironment in the biology and therapy of cancer metastasis.

Authors:  Isaiah J Fidler; Sun-Jin Kim; Robert R Langley
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

Review 4.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

5.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

6.  A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.

Authors:  Dezheng Dong; Christopher Stapleton; Biquan Luo; Shigang Xiong; Wei Ye; Yi Zhang; Niyati Jhaveri; Genyuan Zhu; Risheng Ye; Zhi Liu; Kevin W Bruhn; Noah Craft; Susan Groshen; Florence M Hofman; Amy S Lee
Journal:  Cancer Res       Date:  2011-04-05       Impact factor: 12.701

Review 7.  The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Authors:  Ju Dong Yang; Ikuo Nakamura; Lewis R Roberts
Journal:  Semin Cancer Biol       Date:  2010-10-12       Impact factor: 15.707

8.  Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.

Authors:  Kohji Okada; Tatsuo Shimura; Taketoshi Suehiro; Erito Mochiki; Hiroyuki Kuwano
Journal:  Anticancer Res       Date:  2006 Mar-Apr       Impact factor: 2.480

Review 9.  The organ microenvironment and cancer metastasis.

Authors:  Isaiah J Fidler
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

Review 10.  Inflammation and melanoma metastasis.

Authors:  Vladislava O Melnikova; Menashe Bar-Eli
Journal:  Pigment Cell Melanoma Res       Date:  2009-04-08       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.